ClinConnect ClinConnect Logo
Search / Trial NCT02248363

Nationwide Evaluation of Multimodal Rehabilitation in Patients With Chronic Musculoskeletal Pain

Launched by KAROLINSKA INSTITUTET · Sep 21, 2014

Trial Information

Current as of June 27, 2025

Unknown status

Keywords

Rehabilitation Effectiveness Determinants Prediction

ClinConnect Summary

Chronic musculoskeletal pain is a public health problem, which frequently cause long-term sickness absence (\>180 days). Societal costs of chronic pain are immense, with direct and indirect costs amounting to 90 billion Swedish crowns per year according to Swedish Council on Technology Assessment (SBU). Despite this, few policies have aimed specifically at chronic pain as a public health problem, also acknowledged in the later literature. Multimodal rehabilitation (MMR) is an increasingly used method in this patient group and denotes a combination of psychological measures, physical activit...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chronic pain, e.g. long-term neck and back pain or progressed generalized widespread pain that has lasted more than three months
  • 18 to 67 yrs old
  • Referred to one of the specialist MMR-clinical department in Sweden
  • Exclusion Criteria:
  • - Malignancies

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Huddinge, Stockholm, Sweden

Patients applied

0 patients applied

Trial Officials

Björn Äng, Assoc prof.

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials